|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 48, Issue 4 211-228, Copyright © 1998 by American Cancer Society
J. F. Carew and J. P. Shah
Combined induction chemotherapy and external beam radiation therapy is an
effective treatment for selected patients with advanced-stage laryngeal
cancer. The larynx can be preserved in two-thirds of patients receiving
this treatment. Investigations continue to evaluate the ideal treatment
regimen, the delivery of chemotherapy, patient selection, biologic markers
predicting response, functional outcome, and the effectiveness of this
treatment at other sites.
ARTICLES
Advances in multimodality therapy for laryngeal cancer
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
This article has been cited by other articles:
![]() |
T. D. Woodard, A. Oplatek, and G. J. Petruzzelli Life After Total Laryngectomy: A Measure of Long-term Survival, Function, and Quality of Life Arch Otolaryngol Head Neck Surg, June 1, 2007; 133(6): 526 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Groome, B. O'Sullivan, J. C. Irish, D. M. Rothwell, K. Schulze, P. R. Warde, K. M. Schneider, R. G. Mackenzie, D. I. Hodson, J. A. Hammond, et al. Management and Outcome Differences in Supraglottic Cancer Between Ontario, Canada, and the Surveillance, Epidemiology, and End Results Areas of the United States J. Clin. Oncol., February 1, 2003; 21(3): 496 - 505. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |